We’ve had a mild fall on Michigan’s Keweenaw Peninsula with no snow or frost yet, though we often have both before November arrives. But even with our good weather, I’m steeling myself to face the coming winter. I drained my hoses and hung them on the garage wall. I picked…
Discussion
People with amyotrophic lateral sclerosis (ALS) may share genetic roots with people who have other neurodegenerative conditions, including frontotemporal dementia (FTD), even when no family connection is known, a new study suggests. The findings highlight the genetic overlap across the ALS-FTD disease spectrum and suggest that conventional family histories may…
Discussion
A pivotal Phase 2/3 clinical trial comparing the experimental oral therapy CB03-154 with a placebo in people with amyotrophic lateral sclerosis (ALS) has completed enrollment in China, developer Zhimeng Biopharma announced. China’s Center for Drug Evaluation (CDE) cleared the trial to begin last year. It…
Discussion
President Donald Trump has signed into law legislation to renew the Accelerating Access to Critical Therapies (ACT) for amyotrophic lateral sclerosis (ALS), a federal program aimed at supporting ALS research and helping patients access promising experimental therapies. The original ACT for ALS was signed into law in 2021…
Discussion
A wide range of potentially modifiable factors related to lifestyle, the environment, mental and physical health, and socioeconomic circumstances may be linked to the risk of developing amyotrophic lateral sclerosis (ALS), a study in China suggests. The researchers identified 45 factors significantly associated with ALS in an analysis of…
Discussion
The ALS Society of Canada is calling on the federal government to invest CAD$50 million over five years in a national initiative aimed at accelerating research, expanding clinical trial access, and advancing the search for treatments for amyotrophic lateral sclerosis (ALS). More than 40 people living with ALS,…
Discussion
The United States Congress recently passed legislation to support five more years of ALS research and expand access to promising experimental therapies. We cannot afford to waste a moment. On Sept. 28, Congress passed the Accelerating Access to Critical Therapies for ALS (ACT for ALS) Reauthorization Act, which would…
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Becoming educated and informed about ALS is a good first step. Here you’ll find general information about the disease, including diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnists’ words of wisdom to help you along on your ALS journey.
There is no cure for ALS yet, but here you can find more information about current therapeutic approaches, as well as experimental treatments that are in the pipeline.
